- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07588048
Morton Toe and Neuromuscular Performance
Morton Toe is Associated With Faster Contractile Properties and Superior Reactive Strength in Female Football Players
Visão geral do estudo
Status
Descrição detalhada
Morton toe is a congenital foot morphology characterized by a longer second metatarsal relative to the first. Although traditionally regarded as a clinical or orthopedic variation associated with metatarsal stress fractures and balance difficulties, limited evidence from sprinter populations suggests that a longer second toe may be associated with superior athletic performance. However, no previous study has examined whether Morton toe morphology is related to neuromuscular contractile properties assessed via tensiomyography or kinetic performance derived from force plate testing in a controlled group comparison design.
Participants were screened from 97 female football players. Exclusion criteria included BMI outside the 18.5-29.9 range, bilateral arch index outside the 14-29% range, inconsistent bilateral foot morphology, lower-extremity injury within the past 12 months, neurological or orthopedic conditions, performance-affecting pharmacological use, and menstruation on the measurement day. Morton toe classification was based on the palpation method described by Davidson et al. (2007) with a minimal detectable change threshold of ±0.30 mm.
All measurements were conducted during the off-season to minimize training load interference. Testing followed a standardized sequence: foot morphology assessment, tensiomyography of the dominant vastus lateralis at rest, a 15-minute warm-up, and a 40-cm drop jump test. The assessor was blinded to group classification, and statistical analysis was performed by an independent researcher on a coded dataset. Primary outcome variables (Tc and RSI) were determined a priori. Secondary outcomes were corrected for multiple comparisons using the Holm-Bonferroni method. Regression analyses were performed to assess the independence of group effects from age, body mass index, and mean bilateral arch index.
Tipo de estudo
Inscrição (Real)
Contactos e Locais
Locais de estudo
-
-
Centre
-
Giresun, Centre, Turquia (Türkiye), 28100
- Giresun University - Sports Science Faculty
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- Active female football players with a valid sports license for the current season
- Regular participation in training and competitive matches
- Bilateral Morton toe morphology (Δ ≤ -0.30 mm on both feet) or bilateral normal foot morphology (Δ > +0.30 mm on both feet)
- Body mass index between 18.5 and 29.9 kg/m²
- Bilateral arch index between 14% and 29%
- Voluntary participation with written informed consent
Exclusion Criteria:
- Serious lower-extremity musculoskeletal injury within the past 12 months
- Neurological or orthopedic disease affecting measurement procedures
- Current use of pharmacological products affecting performance
- Acute pain, injury, or illness on the measurement day
- Menstruation on the measurement day (self-reported)
- Inconsistent bilateral foot morphology classification between feet
- Bilateral arch index below 14% (high arch) or above 29% (low arch)
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
|---|
|
Morton Foot Group
Female football players with bilateral Morton toe morphology, defined as a second metatarsal protrusion distance exceeding the first by more than 0.30 mm bilaterally (Δ ≤ -0.30 mm).
n = 24.
|
|
Normal Foot Group
Female football players with bilateral normal foot morphology, defined as a first metatarsal protrusion distance exceeding the second by more than 0.30 mm bilaterally (Δ > +0.30 mm).
n = 23.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Contraction Time (Tc)
Prazo: Single measurement session
|
Tensiomyographic contraction time of the dominant vastus lateralis muscle, defined as the time between 10% and 90% of maximal radial displacement (ms).
|
Single measurement session
|
|
Reactive Strength Index (RSI)
Prazo: Single measurement session
|
Jump height divided by ground contact time during a 40-cm drop jump test (m/s).
The trial with the highest RSI value out of three attempts was selected for analysis.
|
Single measurement session
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Maximal Displacement (Dm)
Prazo: Single measurement session
|
Peak radial displacement of the vastus lateralis muscle belly during tensiomyographic measurement (mm).
|
Single measurement session
|
|
Relaxation Time (Tr)
Prazo: Single measurement session
|
Time from 90% to 50% of maximal displacement during the relaxation phase of tensiomyographic measurement (ms).
|
Single measurement session
|
|
Delay Time (Td)
Prazo: Single measurement session
|
Time from electrical stimulus onset to 10% of maximal displacement during tensiomyographic measurement (ms).
|
Single measurement session
|
|
Sustain Time (Ts)
Prazo: Single measurement session
|
Duration the muscle response remains above 50% of maximal displacement during tensiomyographic measurement (ms).
|
Single measurement session
|
|
Jump Height (JH)
Prazo: Single measurement session
|
Vertical jump height calculated from flight time during a 40-cm drop jump test (cm).
|
Single measurement session
|
|
Peak Power Normalized to Body Mass (PPI)
Prazo: Single measurement session
|
Peak power output normalized to body mass during a 40-cm drop jump test (W/kg).
|
Single measurement session
|
|
Landing Net Peak Force Normalized to Body Mass (LPF)
Prazo: Single measurement session
|
Peak vertical ground reaction force at landing normalized to body mass during a 40-cm drop jump test (N/kg).
|
Single measurement session
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- GRU-SBF-NS-06
- 10/492 (Outro identificador: Giresun University Social Sciences, Natural Sciences and Engineering Research Ethics Committee)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .